Click Here |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: June 2023
Volume 8 | Issue 6
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 8
Issue Published : 85
Article Submitted : 7821
Article Published : 4002
Total Authors : 10443
Total Reviewer : 547
Total Countries : 81
Indexing Partner
Licence
Published Paper Details
|
|
Paper Title: | A Review on liquid chromatographic method for estimation of Dabigatran, Apixaban and Ticagrelor |
Authors Name: | Akash Sunil Gadekar , Uday A. Deokate |
Download E-Certificate: | Download |
Author Reg. ID: |
IJRTI_181591
|
Published Paper Id: | IJRTI2108006 |
Published In: | Volume 6 Issue 8, August-2021 |
DOI: | |
Abstract: | In the present era, the best common analytical method used for quantification of the drug is Reverse phase high-pressure liquid chromatography because of advantages like high accuracy, high sensitivity, and least time-consuming. DABIGATRAN is in a class of anticoagulant drugs. It is a direct thrombin inhibitor that prevents the formation of blood clots in the body. Dabigatran is also used to prevent strokes and severe blood clots in the individuals with atrial fibrillation without heart valve disease. APIXABAN is a specific novel anticoagulant drug which is used for treatment of thromboembolism. Apixaban is an oral anticoagulant and direct, selective inhibitor of factor Xa, which is used to decrease the risk of venous thrombosis, stroke and systemic embolization in patients with atrial fibrillation. TICAGRELOR is a cyclopentytriazolopyrimidine-based platelet aggregation inhibitor that is used orally. It's a P2Y12 receptor antagonist that suppresses platelet activation and accumulation triggered by P2Y12 and ADP receptor in myocardial infarction. In this study, we will look at all documented HPLC and LC-MS methods for determining specific anticoagulant medicines including dabigatran, Apixaban, and Ticagrelor in their pure form, combination form with other drugs, combined form with degradation products, and in biological fluids. |
Keywords: | RP-HPLC, LC-MS, Dabigatran, Apixaban, Ticagrelor. |
Cite Article: | "A Review on liquid chromatographic method for estimation of Dabigatran, Apixaban and Ticagrelor", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.6, Issue 8, page no.31 - 42, August-2021, Available :http://www.ijrti.org/papers/IJRTI2108006.pdf |
Downloads: | 000202441 |
ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
Publication Details: |
Published Paper ID: IJRTI2108006
Registration ID:181591
Published In: Volume 6 Issue 8, August-2021
DOI (Digital Object Identifier):
Page No: 31 - 42 Country: Ahmednagar, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2108006 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2108006 |
Share Article: | |
Click Here to Download This Article |
|
Article Preview | |
|
Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
![]() |
![]() |
![]() |
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
![]() Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
Important Details
Social Media
Indexing Partner |
|||
Copyright © 2023 - All Rights Reserved - IJRTI |
Facebook Twitter Instagram LinkedIn